中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2014年
15期
117-118
,共2页
子宫内膜异位症%手术治疗%复发因素
子宮內膜異位癥%手術治療%複髮因素
자궁내막이위증%수술치료%복발인소
Endometriosis%Surgical treatment%Recurrence factors
目的:分析子宫内膜异位症治疗后的复发因素。方法:选择2011年1月-2013年11月笔者所在医院收治的120例子宫内膜异位症患者,回顾性分析其临床资料,根据治疗方法不同将其分为A、B、C三组,其中保守手术治疗的56例患者为A组,半保守手术治疗的36例患者为B组,根治性手术治疗的28例患者为C组,探讨治疗后复发的相关因素。结果:经随访13例患者复发,A组术后复发率为19.64%(11/56),B组复发率为5.56%(2/36),C组的复发率为0,A组复发率明显高于B组和C组,差异有统计学意义(P<0.05)。经统计该病复发相关因素主要包括年龄、疾病分期及术后药物治疗。结论:临床治疗子宫内膜异位症时需要根据患者年龄、病理类型、疾病分期合理选择治疗方式,术后协同药物来预防复发。
目的:分析子宮內膜異位癥治療後的複髮因素。方法:選擇2011年1月-2013年11月筆者所在醫院收治的120例子宮內膜異位癥患者,迴顧性分析其臨床資料,根據治療方法不同將其分為A、B、C三組,其中保守手術治療的56例患者為A組,半保守手術治療的36例患者為B組,根治性手術治療的28例患者為C組,探討治療後複髮的相關因素。結果:經隨訪13例患者複髮,A組術後複髮率為19.64%(11/56),B組複髮率為5.56%(2/36),C組的複髮率為0,A組複髮率明顯高于B組和C組,差異有統計學意義(P<0.05)。經統計該病複髮相關因素主要包括年齡、疾病分期及術後藥物治療。結論:臨床治療子宮內膜異位癥時需要根據患者年齡、病理類型、疾病分期閤理選擇治療方式,術後協同藥物來預防複髮。
목적:분석자궁내막이위증치료후적복발인소。방법:선택2011년1월-2013년11월필자소재의원수치적120례자궁내막이위증환자,회고성분석기림상자료,근거치료방법불동장기분위A、B、C삼조,기중보수수술치료적56례환자위A조,반보수수술치료적36례환자위B조,근치성수술치료적28례환자위C조,탐토치료후복발적상관인소。결과:경수방13례환자복발,A조술후복발솔위19.64%(11/56),B조복발솔위5.56%(2/36),C조적복발솔위0,A조복발솔명현고우B조화C조,차이유통계학의의(P<0.05)。경통계해병복발상관인소주요포괄년령、질병분기급술후약물치료。결론:림상치료자궁내막이위증시수요근거환자년령、병리류형、질병분기합리선택치료방식,술후협동약물래예방복발。
Objective:To analyze the recurrence factors of endometriosis after treatment.Method:120 cases with endometriosis from January 2011 to November 2013 in the author’s hospital were selected,which were retrospectively analyzed the clinical data,according to different treatment the patients were divided into three groups A,B,C,including conservative surgical treatment of 56 cases in group A,including conservative surgical treatment for 36 cases in group B, radical surgical treatment of 28 cases in group C,to explore the related factors of recurrence after treatment.Result:After follow-up of 13 patients with recurrence, postoperative recurrence rate was 19.64%(11/56) in group A,group B recurrence rate was 5.56%(2/36),group C recurrence rate was 0,the recurrence rate of group A was significantly higher than group B and group C,the difference was statistically significant (P<0.05). Through the disease recurrence related factors including age,disease stage and postoperative medication.Conclusion:In the clinical treatment of endometriosis,it should choose reasonable treatment plan according to the patient’s age,histological type and stage of disease,and take collaborative drugs to prevent postoperative recurrence.